DiagnaMed Holdings Corp. engages in providing artificial intelligence (AI) healthcare solutions. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2022-11-08. The firm delivers technology solutions for the cleantech and life sciences industries, with a focus on hydrogen production and artificial intelligence (AI)-driven drug discovery and diagnostics. The firm is focused on the commercialization of two technologies, such as a proprietary electromagnetic heating technology enabling hydrogen production from petroleum reservoirs and natural hydrogen fields, and BRAIN AGE BRAIN HEALTH, a proprietary brain health AI platform for the healthcare market. Its Brain Tremor is an investigating technological application that monitors, collects and uses individual information to detect tremors, and measure cognitive and brain activity in patients with neurological disorders. BRAIN AGE Brain Health is a brain health AI platform that aims to predict and monitor brain age and provide actionable insights into mental health and neurodegenerative disorders.
Follow-Up Questions
Quelle est la performance du prix de l'action DGNMF ?
Le prix actuel de DGNMF est de $0.0585, il a decreased de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de DiagnaMed Holdings Corp ?
DiagnaMed Holdings Corp appartient à l'industrie N/A et le secteur est N/A
Quel est la capitalisation boursière de DiagnaMed Holdings Corp ?
La capitalisation boursière actuelle de DiagnaMed Holdings Corp est de $6.3M
